1. Oral Therapies in Myeloma: Medication Adherence

    Learn about the importance of taking treatments as prescribed by the doctors, tips to help patients take oral medication as prescribed, and tips and strategies for successful communication with the healthcare team.

    Read More
  2. Keeping a Good Weight during Treatment: Unwanted Weight Loss

    Why is your weight the first thing people often notice about you? What’s so important about being weighed each time you have an appointment with your health care team? Well, a healthy weight is crucial during cancer. Body weight is one of the vital signs or body measurements that are monitored during cancer treatments. Just as blood pressure and pulse reflect your health at one point in time, your body weight pattern too gives insight into your health. Changes in your weight may come fr...

    Read More
  3. LLS Announces Progress Against Devastating Disease

    White Plains, NY, March 14, 2016 – An investigational therapy supported by The Leukemia & Lymphoma Society (LLS) performed significantly better than the standard therapy in a Phase 3 clinical trial for patients with high-risk (secondary) acute myeloid leukemia (AML), its developer announced today. AML remains the deadliest of all blood cancers, and there have been no new therapies for nearly 40 years. LLS funded the Phase 3 clinical trial through its Therapy Acceleration Program® ...

    Read More
  4. Learning to “Live” with Myeloma

    By definition a survivor is a person who copes with difficulties in their life. In 2006, my 80-year-old father was diagnosed with multiple myeloma. Like most people, I had no idea what that meant. After doing some research, I discovered it to be a cancer of the plasma cells in the bone marrow, which can be treated but not cured. He was diabetic and had heart disease, there weren’t many treatments, so options were limited. He passed within ten months. I didn’t realize it then but he showe...

    Read More
  5. FDA Update: Recent Approvals Benefit Blood Cancer Patients

    Ibrutinib just became the latest therapy for blood cancers to receive an expanded approval use by the U.S. Food and Drug Administration. Such therapeutic advances have been making great progress in recent months and a number of investigational agents – first approved for one disease and population – are being expanded to new uses. Almost 300 drugs for blood cancers are currently in clinical trials or awaiting FDA review.

    Read More
  6. My Myeloma Story

    “What is multiple myeloma?” Those were my words after the doctor’s review of my lab results for a routine and random high blood pressure exam in November 2008. I had always been healthy, had never been in the hospital, never even broken a bone. I was in great shape: a 46-year-old high school biology teacher, head softball and volleyball coach, with a beautiful young family including two teenage daughters. I got not only cancer, but an incurable form of cancer. The diagnosis was confi...

    Read More
  7. Looking Ahead: LLS Panel Highlights Trends and Advances

    The Leukemia & Lymphoma Society recently brought together a world-renowned panel of thought leaders to discuss the latest advances and insights into blood cancer research and treatment, drug costs and patient access, and patient advocacy and policy. “There’s never a good time to get cancer but this is a phenomenal time to be fighting it,” said Louis J. DeGennaro, president and CEO of The Leukemia & Lymphoma Society (LLS).

    Read More
  8. Leading Researchers, Clinicians, Policy and Drug Development Experts, and Cancer Survivors Convene to Discuss Latest Advances and Challenges in Treating Blood Cancers

    Click here for a comprehensive media toolkit. New York – February 25, 2016 – A panel of world renowned thought leaders from research, clinical practice, policymaking, pharmaceutical industry and patient advocacy convened today to discuss and debate the latest advances and insights into blood cancer research and treatment, drug costs and patient access, and patient advocacy and policy. The roundtable was organized by The Leukemia & Lymphoma Society (LLS), the world's largest volunta...

    Read More
  9. Coming Soon: A Brave New World

    Research is inching us closer to cures for blood cancer every day – among them, therapies that unleash the immune system, reprogramming of T-cells to track down cancer cells, and personalized treatments based on a patient’s genetic make-up. Survival rates for patients with many blood cancers have doubled, tripled and even quadrupled since the early 1960s. Cures for many patients with acute lymphoblastic leukemia (ALL) and Hodgkin lymphoma have been achieved, and the five-year survival ...

    Read More
  10. Seven Insights for Better Nutrition During Cancer Treatment

    In the New Year, you may be looking to turn over a new leaf. One goal may be to improve your nutrition. Many cancer survivors struggle with food issues. In fact, research shows that up to 80 percent of people with a cancer diagnosis are expected to experience malnutrition at some point during treatment. Even before a diagnosis, as many as 40 percent of people with cancer experience unhealthy weight loss. Unhealthy weight loss can lead to decreased response to treatment, delays in treatment, a...

    Read More